Lv4
498 积分 2025-04-11 加入
The expanding role of formulations to enable oral delivery of poorly water-soluble drugs
12天前
已完结
Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers
1个月前
已完结
A case study where pharmaceutical salts were used to address the issue of low in vivo exposure
1个月前
已完结
PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
3个月前
已完结
A New Wave of PI3Kα Inhibitors
3个月前
已完结
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy
3个月前
已完结
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer
3个月前
已完结
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
3个月前
已完结
The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity
3个月前
已完结
AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery
3个月前
已完结
皖公网安备34019202002308
